Is the new U.S. regulation an open door or obstacle for K-sunscreens? The U.S. Food and Drug Administration (FDA) has cleared bemotrizinol for use in sun care products, but Korean sunscreen makers still face exclusivity limits, reformulation work and drug-level regulations. 2026.8.12
